Weill Cornell Medicine at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

Weill Cornell Medicine brings 2 presentations to ISLB 2026 in Madrid. Its work centres on circulating tumour cells, from where the field stands now to new ways of finding them. One study tests NMC, a cancer-associated membrane marker, for detecting these cells in metastatic breast cancer without relying on EpCAM.

OrganizationISLB 2026 Attendance
weill.cornell.edu
Universities & research institutes
Cornell University's medical school and biomedical research enterprise in New York City.
Talk
Sun Nov 8
5:30pm–6:30pm
Poster

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Weill Cornell Medicine

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction